Literature DB >> 19502959

Orthotopic liver transplantation: T-tube or not T-tube? Systematic review and meta-analysis of results.

Georgios C Sotiropoulos1, George Sgourakis, Arnold Radtke, Ernesto P Molmenti, Konstantinos Goumas, Sofia Mylona, Ioannis Fouzas, Constantine Karaliotas, Hauke Lang.   

Abstract

BACKGROUND: The purpose of this study was to compare outcomes after duct-to-duct anastomoses with or without biliary T-tube in orthotopic liver transplantation.
METHODS: We pooled the outcomes of 1027 patients undergoing choledocho-choledochostomy with or without T-tube in 9 of 46 screened trials by means of fixed or random effects models.
RESULTS: The "without T-tube" and "with T-tube" groups had equivalent outcomes for: anastomotic bile leaks or fistulas, choledocho-jejunostomy revisions, dilatation and stenting, hepatic artery thromboses, retransplantation, and mortality due to biliary complications. The "without T-tube" group had better outcomes when considering "fewer episodes of cholangitis," "fewer episodes of peritonitis," and showed a favorable trend for "overall biliary complications." Although the "with T-tube" group showed superior result for "anastomotic and nonanastomotic strictures," the incidence of interventions was not diminished.
CONCLUSIONS: Our systematic review and meta analysis favor the abandonment of T-tubes in orthotopic liver transplantation.

Entities:  

Mesh:

Year:  2009        PMID: 19502959     DOI: 10.1097/TP.0b013e3181a5cf3f

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  24 in total

Review 1.  [Antibiotic prophylaxis and endoluminal tubes].

Authors:  C Justinger; M K Schilling
Journal:  Chirurg       Date:  2011-12       Impact factor: 0.955

Review 2.  Biliary complications following liver transplantation.

Authors:  Walid S Ayoub; Carlos O Esquivel; Paul Martin
Journal:  Dig Dis Sci       Date:  2010-04-22       Impact factor: 3.199

3.  Risk factors of biliary intervention by imaging after living donor liver transplantation.

Authors:  Soon Kyu Lee; Jong Young Choi; Dong Myung Yeo; Young Joon Lee; Seung Kew Yoon; Si Hyun Bae; Jeong Won Jang; Hee Yeon Kim; Dong Goo Kim; Young Kyoung You
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

4.  Value of T-tube in biliary tract reconstruction during orthotopic liver transplantation: a meta-analysis.

Authors:  Wei-dong Huang; Jiu-kun Jiang; Yuan-qiang Lu
Journal:  J Zhejiang Univ Sci B       Date:  2011-05       Impact factor: 3.066

5.  Biliary Duct-to-Duct Reconstruction with a Tunneled Retroperitoneal T-Tube During Liver Transplantation: a Novel Approach to Decrease Biliary Leaks After T-Tube Removal.

Authors:  Julie Navez; Kayvan Mohkam; Benjamin Darnis; Jean-Baptiste Cazauran; Christian Ducerf; Jean-Yves Mabrut
Journal:  J Gastrointest Surg       Date:  2016-11-04       Impact factor: 3.452

6.  External biliary drainage following major liver resection for perihilar cholangiocarcinoma: impact on development of liver failure and biliary leakage.

Authors:  Pim B Olthof; Robert J S Coelen; Jimme K Wiggers; Marc G H Besselink; Olivier R C Busch; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2016-02-18       Impact factor: 3.647

7.  Management of Biliary Strictures After Liver Transplantation.

Authors:  Nicolas A Villa; M Edwyn Harrison
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-05

Review 8.  Bile Duct Injury after Cholecystectomy: Surgical Therapy.

Authors:  Bernhard W Renz; Florian Bösch; Martin K Angele
Journal:  Visc Med       Date:  2017-05-26

9.  Internal biliary stenting in liver transplantation.

Authors:  Edouard Girard; Olivier Risse; Julio Abba; Maud Medici; Vincent Leroy; Mircea Chirica; Christian Letoublon
Journal:  Langenbecks Arch Surg       Date:  2018-03-24       Impact factor: 3.445

Review 10.  Biliary complications following liver transplantation.

Authors:  Gursimran Kochhar; Jose Mari Parungao; Ibrahim A Hanouneh; Mansour A Parsi
Journal:  World J Gastroenterol       Date:  2013-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.